Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening

P Desjeux, 2004, Leishmaniasis: current situation and new perspectives, Comp Immunol Microbiol Infect Dis, 27, 305, 10.1016/j.cimid.2004.03.004

PJ Hotez, 2012, Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control, PLoS neglected tropical diseases, 6, e1475, 10.1371/journal.pntd.0001475

EM Moore, 2010, Treatment of visceral leishmaniasis, J Glob Infect Dis, 2, 151, 10.4103/0974-777X.62883

B Zulfiqar, 2017, Leishmaniasis drug discovery: recent progress and challenges in assay development, Drug discovery today, 22, 1516, 10.1016/j.drudis.2017.06.004

G Colotti, 2013, Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs, Future medicinal chemistry, 5, 1861, 10.4155/fmc.13.146

A Fiorillo, 2012, The crystal structures of the tryparedoxin-tryparedoxin peroxidase couple unveil the structural determinants of Leishmania detoxification pathway, PLoS neglected tropical diseases, 6, e1781, 10.1371/journal.pntd.0001781

M Brindisi, 2015, Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking, Scientific reports, 5, 9705, 10.1038/srep09705

C Dumas, 1997, Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages, The EMBO journal, 16, 2590, 10.1093/emboj/16.10.2590

P Baiocco, 2009, Molecular basis of antimony treatment in leishmaniasis, Journal of medicinal chemistry, 52, 2603, 10.1021/jm900185q

S Bailey, 1993, Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution, European journal of biochemistry / FEBS, 213, 67, 10.1111/j.1432-1033.1993.tb17734.x

S Patterson, 2011, Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography, Journal of medicinal chemistry, 54, 6514, 10.1021/jm200312v

A Saravanamuthu, 2004, Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design, The Journal of biological chemistry, 279, 29493, 10.1074/jbc.M403187200

P Baiocco, 2011, Inhibitory Effect of Silver Nanoparticles on Trypanothione Reductase Activity and Leishmania infantum Proliferation, ACS medicinal chemistry letters, 2, 230, 10.1021/ml1002629

G Colotti, 2013, Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes, ChemMedChem, 8, 1634, 10.1002/cmdc.201300276

A Ilari, 2012, A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition, Amino acids, 42, 803, 10.1007/s00726-011-0997-9

A Ilari, 2015, Targeting polyamine metabolism for finding new drugs against leishmaniasis: a review, Mini reviews in medicinal chemistry, 15, 243, 10.2174/138955751503150312141044

G Colotti, 2018, Metal- and metalloid-containing drugs for the treatment of trypanosomatid diseases, Front Biosci (Landmark Ed), 23, 954, 10.2741/4628

F Saccoliti, 2017, Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives, Journal of enzyme inhibition and medicinal chemistry, 32, 304, 10.1080/14756366.2016.1250755

B Stump, 2008, Diaryl sulfide-based inhibitors of trypanothione reductase: inhibition potency, revised binding mode and antiprotozoal activities, Organic & biomolecular chemistry, 6, 3935, 10.1039/b806371k

GA Holloway, 2007, Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening, Bioorganic & medicinal chemistry letters, 17, 1422, 10.1016/j.bmcl.2006.11.090

MJ Dixon, 2005, Mechanism and structure-activity relationships of norspermidine-based peptidic inhibitors of trypanothione reductase, Bioorganic & medicinal chemistry, 13, 4513, 10.1016/j.bmc.2005.04.039

D Spinks, 2009, Investigation of trypanothione reductase as a drug target in Trypanosoma brucei, ChemMedChem, 4, 2060, 10.1002/cmdc.200900262

P Baiocco, 2013, Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography, ChemMedChem, 8, 1175, 10.1002/cmdc.201300176

CJ Hamilton, 2006, Time-dependent inhibitors of trypanothione reductase: analogues of the spermidine alkaloid lunarine and related natural products, Bioorganic & medicinal chemistry, 14, 2266, 10.1016/j.bmc.2005.11.004

DC Martyn, 2007, High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity, Bioorganic & medicinal chemistry letters, 17, 1280, 10.1016/j.bmcl.2006.12.016

CJ Hamilton, 2003, Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase, The Biochemical journal, 369, 529, 10.1042/bj20021298

DJ Rogers, 1960, A Computer Program for Classifying Plants, Science, 132, 1115, 10.1126/science.132.3434.1115

P Baiocco, 2009, Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis, Protein and peptide letters, 16, 196, 10.2174/092986609787316306

D. Butina, 1999, Unsupervised Data Base Clustering Based on Daylight's Fingerprint and Tanimoto Similarity: A Fast and Automated Way To Cluster Small and Large Data Sets, J Chem Inf Comput Sci, 39, 4, 10.1021/ci9803381

W. Kabsch, 2010, Xds, Acta crystallographica Section D, Biological crystallography, 66, 125, 10.1107/S0907444909047337

A Vagin, 2010, Molecular replacement with MOLREP, Acta crystallographica Section D, Biological crystallography, 66, 22, 10.1107/S0907444909042589

GN Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method, Acta crystallographica Section D, Biological crystallography, 53, 240, 10.1107/S0907444996012255

P Emsley, 2004, Coot: model-building tools for molecular graphics, Acta crystallographica Section D, Biological crystallography, 60, 2126, 10.1107/S0907444904019158

D Sereno, 1997, Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro, Parasitol Res, 83, 401, 10.1007/s004360050272

G Angiulli, 2015, Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase, Biochimica et biophysica acta, 1850, 1891, 10.1016/j.bbagen.2015.05.022

A Albert, 2012, Speciation analysis of the antirheumatic agent Auranofin and its thiol adducts by LC/ESI-MS and LC/ICP-MS, J Anal Atom Spectrom, 27, 975, 10.1039/c2ja30109a

JH Zhang, 1999, A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays, J Biomol Screen, 4, 67, 10.1177/108705719900400206

E Persch, 2014, Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase, ChemMedChem, 9, 1880, 10.1002/cmdc.201402032